e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Mechanisms of pulmonary inflammation and fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of cyclic stretch on stiffness and matrix metalloproteinases (MMPs) in mouse lung tissue strips
E. Bartolak-Suki, R. Jesudason, B. Suki (Boston, United States Of America)
Source:
Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Session:
Mechanisms of pulmonary inflammation and fibrosis
Session type:
Thematic Poster Session
Number:
3616
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Bartolak-Suki, R. Jesudason, B. Suki (Boston, United States Of America). Effects of cyclic stretch on stiffness and matrix metalloproteinases (MMPs) in mouse lung tissue strips. Eur Respir J 2009; 34: Suppl. 53, 3616
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2005; 25: 834-842
Year: 2005
Blood levels of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix matalloproteinases (TIMPs) as biomarkers of COPD.
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
Effects of keratinocyte growth factor (KGF) on matrix metalloproteinases (MMPs) & tissue inhibitors of metalloproteinases (TIMPs) mRNA levels in emphysematous rats lungs
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008
Remodelling of extracellular matrix (ECM) differs between pulmonary adenocarcinoma (Ad) and squamous cell carcinoma (Sq): immunohistochemistry and morphometry of matrix proteins (MPs), matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (TIMPs
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008
Extracellular matrix components and regulators in the airway smooth muscle in asthma
Source: Eur Respir J 2008; 32: 61-69
Year: 2008
Statins inhibit matrix metalloproteinase release from human lung fibroblasts
Source: Eur Respir J 2010; 35: 637-646
Year: 2010
Remodelling of extracellular matrix (ECM) differs between tumor centre and invasion front in human non-small cell lung cancer: immunohistochemistry and morphometry of matrix proteins (MP), matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (T
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008
Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension
Source: Eur Respir J 2001; 18: 838-845
Year: 2001
Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in pleural effusions
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011
Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases expression in the bronchial secretions of asthmatics and COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 92s
Year: 2002
Effects of steroids and b-mimetics on matrix metalloproteinases expression in human lung primary cells
Source: Eur Respir J 2003; 22: Suppl. 45, 453s
Year: 2003
Effects of neurotrophins on matrix metalloproteinase production in human bronchial smooth muscle cells
Source: Eur Respir J 2005; 26: Suppl. 49, 128s
Year: 2005
Matrix metalloproteinases and their inhibitors in pulmonary hypertension},
Source: Eur Respir J 2012; 40: 766-782
Year: 2012
Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF
Source: Eur Respir J 2002; 20: 1220-1227
Year: 2002
Matrix metalloproteinases (MMPs) and angiogenesis in lung tissue remodeling in different variants of idiopathic interstitial pneumonia (IIP)
Source: Eur Respir J 2007; 30: Suppl. 51, 137s
Year: 2007
Biological role of matrix metalloproteinases: a critical balance
Source: Eur Respir J 2011; 37: 191-208
Year: 2011
Expression of matrix metalloproteinases in pigs with hyperoxia-induced acute lung injury
Source: Eur Respir J 2001; 18: 827-837
Year: 2001
Matrix metalloproteinases 2 and 9 increase the permeability of sheep pleura: Mechanisms of action
Source: Annual Congress 2010 - Proteases and the matrix
Year: 2010
Matrix metalloproteinases in lung repair
Source: Eur Respir J 2003; 22: 36S-38S
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept